| abstract |
The present invention relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula (IA) or (IB): n nas further described herein. The invention also relates to methods for the preparation of the compounds, and to pharmaceutical compositions containing such compounds. |